All In Biotech

Free tool

FAERS Monitor: Glyrx-Pf

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210997 or its brand name (Glyrx-Pf, Glycopyrrolate). Reports on generic versions are filed under their own applications.

Reports

5,532

Serious

4,665

84% of reports

Hospitalization

2,346

Death reported

660

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,055
  • asthma852
  • wheezing719
  • cough669
  • pneumonia576
  • drug ineffective446
  • off label use374
  • fatigue373
  • malaise365
  • chronic obstructive pulmonary disease361
  • productive cough350
  • chest discomfort337
  • nausea336
  • condition aggravated323
  • therapeutic product effect incomplete317

Reports by year received

View as table
YearReports
200412
200514
200616
200730
200829
200946
201062
201174
201288
201370
2014125
2015134
2016216
2017428
2018291
2019315
2020281
2021444
2022619
2023568
2024605
2025674
2026390

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,627 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal71946.743.631,774
asthmaSignal85228.927.122,848
productive coughSignal35028.125.49,066
chronic obstructive pulmonary diseaseSignal36126.524.08,786
therapeutic product effect incompleteSignal31717.015.34,757
chest discomfortSignal33712.611.33,576
coughSignal6699.18.54,862
dyspnoeaSignal1,0557.16.75,662
pneumoniaSignal5766.86.32,868
condition aggravatedSignal3234.03.6747
malaiseSignal3653.22.9550
fatigue3731.81.7143
off label use3741.61.593
nausea3361.61.581
drug ineffective4461.31.230

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.